Table 1.
Detailed results of erythema, induration, scaliness and LPSI before enrolment into the study and after 3 months of the therapy
| Parameter | Before | After | P-value | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mean | Median | 1st quartile | 3rd quartile | SD | Mean | Median | 1st quartile | 3rd quartile | SD | ||
| Redness | 1.85 | 2.00 | 1.00 | 2.00 | 0.60 | 1.00 | 1.00 | 1.00 | 1.00 | 0.66 | < 0.0001 |
| Induration | 1.80 | 2.00 | 1.00 | 2.00 | 0.80 | 0.54 | 0.00 | 0.00 | 1.00 | 0.72 | < 0.0001 |
| Erythema | 1.60 | 2.00 | 1.00 | 2.00 | 0.93 | 0.43 | 0.00 | 0.00 | 1.00 | 0.67 | < 0.0001 |
| Before | After | ||||||||||
| Parameter | Mean | Median | 1st quartile | 3rd quartile | SD | Mean | Median | 1st quartile | 3rd quartile | SD | P-value |
| Redness | 1.85 | 2.00 | 1.00 | 2.00 | 0.60 | 1.00 | 1.00 | 1.00 | 1.00 | 0.66 | <0.0001 |
| Induration | 1.80 | 2.00 | 1.00 | 2.00 | 0.80 | 0.54 | 0.00 | 0.00 | 1.00 | 0.72 | <0.0001 |
| Erythema | 1.60 | 2.00 | 1.00 | 2.00 | 0.93 | 0.43 | 0.00 | 0.00 | 1.00 | 0.67 | <0.0001 |